Don't get angry ... I'm trying to be constructive. The SP of NYR...

Don't get angry ... I'm trying to be constructive. The SP of NYR will go in cycles - all stocks do - so I'm hanging around in case it looks like they're going to go somewhere.

The DoD comparison is better than guessing - even a blind long must see that.

I'll hang around, initially, until the CR details are revealed ... and then watch the market reaction.

The IP strength or lack of, is significant.

So is the historical success of the KMP's.

Also any competition with other ASX listed companies ... like AGN who have patents, advanced clinical programmes, and are aiming for the same health sub-sector. https://hotcopper.com.au/threads/ann-argenica-to-be-granted-patent-protection-in-the-us.6476450/

It's all valid for comparison from an investment perspective.